Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
A Agilent Technologies	$140.57 +1.9%	$130.88	$108.35 ▼ $160.27	$38.94B	1.25	2.16 million shs	2.28 million shs
BIO Bio-Rad Laboratories	$331.98 +4.9%	$297.02	$236.73 ▼ $343.12	$8.47B	1.08	273,349 shs	592,279 shs
BRKR Bruker	$62.91 +4.8%	$57.07	$28.53 ▼ $64.54	$9.14B	1.29	1.87 million shs	2.56 million shs
TECH Bio-Techne	$72.07 +0.6%	$61.56	$43.19 ▼ $72.16	$11.21B	1.29	4.73 million shs	7.79 million shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
A Agilent Technologies	-0.42%	+5.76%	+1.31%	+20.23%	+14.90%
BIO Bio-Rad Laboratories	+0.85%	+4.81%	+5.43%	+13.18%	+19.83%
BRKR Bruker	-0.66%	+6.91%	-1.41%	+65.61%	+43.18%
TECH Bio-Techne	+0.03%	-0.03%	+0.87%	+33.84%	+21.84%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
A Agilent Technologies	$140.57 +1.9%	$130.88	$108.35 ▼ $160.27	$38.94B	1.25	2.16 million shs	2.28 million shs
BIO Bio-Rad Laboratories	$331.98 +4.9%	$297.02	$236.73 ▼ $343.12	$8.47B	1.08	273,349 shs	592,279 shs
BRKR Bruker	$62.91 +4.8%	$57.07	$28.53 ▼ $64.54	$9.14B	1.29	1.87 million shs	2.56 million shs
TECH Bio-Techne	$72.07 +0.6%	$61.56	$43.19 ▼ $72.16	$11.21B	1.29	4.73 million shs	7.79 million shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
A Agilent Technologies	-0.42%	+5.76%	+1.31%	+20.23%	+14.90%
BIO Bio-Rad Laboratories	+0.85%	+4.81%	+5.43%	+13.18%	+19.83%
BRKR Bruker	-0.66%	+6.91%	-1.41%	+65.61%	+43.18%
TECH Bio-Techne	+0.03%	-0.03%	+0.87%	+33.84%	+21.84%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
A Agilent Technologies	2.89	Moderate Buy	$159.35	13.36% Upside
BIO Bio-Rad Laboratories	1.80	Reduce	$303.33	-8.63% Downside
BRKR Bruker	2.44	Hold	$56.79	-9.73% Downside
TECH Bio-Techne	2.12	Hold	$68.08	-5.54% Downside

Current Analyst Ratings Breakdown

Latest TECH, BRKR, A, and BIO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/15/2026	BRKR Bruker	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold
7/13/2026	BIO Bio-Rad Laboratories	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
7/9/2026	TECH Bio-Techne	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Outperform ➝ Sector Perform	$62.00 ➝ $73.00
7/9/2026	A Agilent Technologies	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Hold	$135.00
7/8/2026	BRKR Bruker	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$44.00 ➝ $60.00
7/7/2026	BRKR Bruker	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$60.00 ➝ $70.00
7/6/2026	TECH Bio-Techne	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
6/30/2026	TECH Bio-Techne	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold
6/29/2026	TECH Bio-Techne	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$65.00 ➝ $73.00
6/29/2026	BRKR Bruker	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$50.00 ➝ $70.00
6/26/2026	TECH Bio-Techne	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$70.00 ➝ $73.00

(Data available from 7/28/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
A Agilent Technologies	$6.95B	5.71	$6.76 per share	20.79	$23.78 per share	5.91
BIO Bio-Rad Laboratories	$2.58B	3.44	$10.52 per share	31.57	$276.16 per share	1.20
BRKR Bruker	$3.44B	2.79	$3.54 per share	17.79	$16.28 per share	3.86
TECH Bio-Techne	$1.22B	9.25	$2.46 per share	29.30	$12.24 per share	5.89

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
A Agilent Technologies	$1.30B	$4.98	28.23	21.33	2.45	19.55%	24.33%	12.99%	7/30/2026 (Confirmed)
BIO Bio-Rad Laboratories	$759.90M	$6.07	54.69	35.70	N/A	6.52%	3.56%	2.49%	8/4/2026 (Confirmed)
BRKR Bruker	-$8.60M	-$0.24	N/A	25.78	1.92	-0.65%	11.60%	4.25%	8/4/2026 (Estimated)
TECH Bio-Techne	$73.40M	$0.69	104.45	40.95	8.53	9.05%	13.57%	10.66%	8/5/2026 (Estimated)

Latest TECH, BRKR, A, and BIO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2026	Q4 2026	TECH Bio-Techne	$0.52	N/A	N/A	N/A	$314.65 million	N/A
8/4/2026	Q2 2026	BIO Bio-Rad Laboratories	$1.75	N/A	N/A	N/A	$623.99 million	N/A
8/4/2026	Q2 2026	BRKR Bruker	$0.38	N/A	N/A	N/A	$853.57 million	N/A
5/27/2026	Q2 2026	A Agilent Technologies	$1.41	$1.49	+$0.08	$1.20	$1.80 billion	$1.84 billion
5/6/2026	Q1 2026	BRKR Bruker	$0.23	$0.31	+$0.08	$0.02	$795.62 million	$823.40 million
5/6/2026	Q3 2026	TECH Bio-Techne	$0.55	$0.53	-$0.02	$0.32	$316.11 million	$311.42 million
4/30/2026	Q1 2026	BIO Bio-Rad Laboratories	$1.97	$1.89	-$0.08	-$19.55	$589.91 million	$592.10 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
A Agilent Technologies	$1.02	0.73%	+6.58%	20.48%	9 Years
BIO Bio-Rad Laboratories	N/A	N/A	N/A	N/A	N/A
BRKR Bruker	$0.20	0.32%	+4.56%	N/A	N/A
TECH Bio-Techne	$0.32	0.44%	N/A	46.38%	N/A

Latest TECH, BRKR, A, and BIO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/20/2026	A Agilent Technologies	quarterly	$0.2550	0.77%	6/30/2026	6/30/2026	7/22/2026
5/14/2026	BRKR Bruker	quarterly	$0.05	0.35%	6/22/2026	6/22/2026	7/7/2026
5/6/2026	TECH Bio-Techne	quarterly	$0.08	0.72%	5/18/2026	5/18/2026	5/29/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
A Agilent Technologies	0.43	2.10	1.62
BIO Bio-Rad Laboratories	0.12	3.21	2.37
BRKR Bruker	0.67	1.55	0.72
TECH Bio-Techne	0.10	4.49	3.18

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
A Agilent Technologies	N/A
BIO Bio-Rad Laboratories	65.24%
BRKR Bruker	79.52%
TECH Bio-Techne	98.95%

Insider Ownership

Company	Insider Ownership
A Agilent Technologies	N/A
BIO Bio-Rad Laboratories	30.34%
BRKR Bruker	27.20%
TECH Bio-Techne	1.30%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
A Agilent Technologies	18,100	282.43 million	N/A	Optionable
BIO Bio-Rad Laboratories	7,450	26.76 million	18.64 million	Optionable
BRKR Bruker	11,085	152.23 million	110.82 million	Optionable
TECH Bio-Techne	3,100	156.57 million	154.53 million	Optionable

TECH, BRKR, A, and BIO Headlines

Recent News About These Companies

Technegas Secures Preferred Status in Landmark U.S. Lung Imaging Guidelines

2 hours ago | tipranks.com

Bio-Techne (NASDAQ:TECH) Sets New 52-Week High - Should You Buy?

July 28 at 3:59 PM | marketbeat.com

Ruane Cunniff & Goldfarb L.P. Boosts Stock Position in Bio-Techne Corp $TECH

July 28 at 6:47 AM | marketbeat.com

Eversept Partners LP Trims Stake in Bio-Techne Corp $TECH

July 28 at 6:31 AM | marketbeat.com

Maverick Capital Ltd. Has $247.70 Million Stock Holdings in Bio-Techne Corp $TECH

July 28 at 6:00 AM | marketbeat.com

Ashford Capital Management Inc. Trims Stake in Bio-Techne Corp $TECH

July 28 at 3:44 AM | marketbeat.com

American Capital Management Inc. Boosts Stock Holdings in Bio-Techne Corp $TECH

July 28 at 3:43 AM | marketbeat.com

Brokerages Set Bio-Techne Corp (NASDAQ:TECH) Target Price at $68.08

July 28 at 3:29 AM | americanbankingnews.com

Bio-Techne Corp $TECH Shares Sold by Bradley Foster & Sargent Inc. CT

July 27 at 4:00 AM | marketbeat.com

First Trust Advisors LP Raises Stake in Bio-Techne Corp $TECH

July 26 at 3:44 AM | marketbeat.com

Bio-Techne Corp $TECH Shares Sold by Aristotle Atlantic Partners LLC

July 26 at 3:12 AM | marketbeat.com

Allspring Global Investments Holdings LLC Has $7.82 Million Stake in Bio-Techne Corp $TECH

July 24, 2026 | marketbeat.com

Bio-Techne Corp (NASDAQ:TECH) Receives Consensus Rating of "Hold" from Analysts

July 23, 2026 | marketbeat.com

Jennison Associates LLC Invests $6.23 Million in Bio-Techne Corp $TECH

July 22, 2026 | marketbeat.com

Bank of New York Mellon Corp Sells 31,568 Shares of Bio-Techne Corp $TECH

July 22, 2026 | marketbeat.com

Madison Asset Management LLC Sells 88,250 Shares of Bio-Techne Corp $TECH

July 21, 2026 | marketbeat.com

Bio-Techne Corp $TECH Shares Sold by Baader Bank Aktiengesellschaft

July 21, 2026 | marketbeat.com

What to Expect From Bio-Techne's Next Quarterly Earnings Report

July 20, 2026 | barchart.com

Principal Financial Group Inc. Acquires 33,605 Shares of Bio-Techne Corp $TECH

July 19, 2026 | marketbeat.com

Fifth Third Bancorp Has $7.13 Million Stock Holdings in Bio-Techne Corp $TECH

July 17, 2026 | marketbeat.com

Q1 Earnings Outperformers: Bio-Techne (NASDAQ:TECH) And The Rest Of The Research Tools & Consumables Stocks

July 17, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

TECH, BRKR, A, and BIO Company Descriptions

Agilent Technologies NYSE:A

$140.57 +2.68 (+1.94%)

Closing price 03:59 PM Eastern

Extended Trading

$140.02 -0.55 (-0.39%)

As of 04:49 PM Eastern

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Bio-Rad Laboratories NYSE:BIO

$331.98 +15.57 (+4.92%)

Closing price 03:59 PM Eastern

Extended Trading

$331.00 -0.98 (-0.30%)

As of 05:01 PM Eastern

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Bruker NASDAQ:BRKR

$62.91 +2.86 (+4.76%)

Closing price 04:00 PM Eastern

Extended Trading

$62.28 -0.63 (-1.00%)

As of 05:04 PM Eastern

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Bio-Techne NASDAQ:TECH

$72.07 +0.45 (+0.63%)

Closing price 04:00 PM Eastern

Extended Trading

$72.16 +0.09 (+0.12%)

As of 04:53 PM Eastern

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TECH, BRKR, A, and BIO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TECH, BRKR, A, and BIO Earnings

Compare Dividends

Latest TECH, BRKR, A, and BIO Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TECH, BRKR, A, and BIO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

TECH, BRKR, A, and BIO Company Descriptions

Agilent Technologies NYSE:A

Bio-Rad Laboratories NYSE:BIO

Bruker NASDAQ:BRKR

Bio-Techne NASDAQ:TECH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools